Clinical trial
Impact of Pre-transplant Anti-fibrotic Therapy for Idiopathic Pulmonary Fibrosis Upon Lung Transplant Outcomes
NCT04316780 is registered in ClinicalTrials.gov with Steward St. Elizabeth's Medical Center of Boston, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Pre-transplant Anti-fibrotic Therapy for Idiopathic Pulmonary Fibrosis Upon Lung Transplant Outcomes
- Lead sponsor
- Steward St. Elizabeth's Medical Center of Boston, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 2019
- Completion date
- March 1, 2020
- Enrollment
- 320 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.